Cytokine-induced inflammation and long-term stroke functional outcome

Journal of the Neurological Sciences

Volumn 162, Issue 2, 1999, Pages 185-188

  Vila, N ^a   Filella, X ^a   Deulofeu, R ^a   Ascaso, C ^a   Abellana, R ^a   Chamorro, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Acute phase response; Cytokines; Erythrocyte sedimentation rate; Inflammation; Outcome; Stroke

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOKINE RELEASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL ASSESSMENT; HEART ATRIUM FIBRILLATION; HEART INFARCTION SIZE; HUMAN; IMAGING; INFLAMMATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STROKE;

AGED; BRAIN ISCHEMIA; CHRONIC DISEASE; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; RISK FACTORS; TREATMENT OUTCOME;

EID: 0033556488     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00319-0     Document Type: Article

References (46)

1. Akopov S.E., Simonian N.A., Grigorian G.S. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke. 27:1996;1739-1743.
2. Azzimondi G., Bassein L., Nomino F., Fiorani L., Vignatelli L., Re G., D'Alessandro R. Fever in acute stroke worsens prognosis. Stroke. 26:1995;2040-2043.
3. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor-α. A mediator of focal ischemic brain injury. Stroke. 28:1997;1233-1244.
4. Beamer N.B., Coull B.M., Clark W.M., Hazel J.S., Silberger J.R. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann. Neurol. 37:1995;800-804.
5. Berger L., Hakim A.M. The association of hyperglycemia with cerebral edema in stroke. Stroke. 17:1986;865-871.
6. Bova I.Y., Bornstein N.M., Korczyn A.D. Acute infection as a risk factor for cerebrovascular ischemia. Stroke. 27:1996;2204-2206.
7. Catell J.V., Andus T., Kunz D., Heinrich P.C. Interleukin-6: the major regulator of acute-phase protein synthesis in man and rat. Ann. NY Acad. Sci. 557:1989;87-101.
8. Castillo J., Martinez F., Leira R., Prieto J.M., Lema M., Noya M. Mortality and morbidity of acute cerebral infarction related to temperature and basal analytic parameters. Cerebrovasc. Dis. 4:1994;66-71.
9. Clark W., Hazel J.S., Beamer N., Wynn M., Coull B. The initial acute phase response predicts long term stroke recovery. Stroke. 27:1996;186.
10. Clark W.M. Cytokines and reperfusion injury. Neurology. 49:(Suppl. 4):1997;10-14.
11. Chambers B.R., Norris J., Shurvell B.R., Hachinski V.C. Prognosis of acute stroke. Neurology. 37:1987;221-225.
12. Chamorro A., Vila N., Ascaso C., Saiz A., Montalvo J., Alonso P., Tolosa E. Early prediction of stroke severity: role of the erythrocyte sedimentation rate. Stroke. 26:1995;573-576.
13. Chamorro A., Vila N., Blanc R., Saiz A., Ascaso C., Deulofeu R. The prognostic value of the acute phase response in stroke recurrence. Eur. J. Neurol. 4:1997;491-497.
14. Damasio H.A. Computed tomographic guide to the identification of cerebral vascular territories. Arch. Neurol. 40:1983;138-142.
15. del Zoppo G.J., Schmid-Schönbein G.W., Mori E., Copeland B.R., Chang C.M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 22:1991;1276-1283.
16. Dinarello C.A. Interleukin-1 and the pathogenesis of the acute-phase response. New Engl. J. Med. 311:1984;1413-1418.
17. Elneihoum A.M., Falke P., Axelson L., Lundberg E., Lindgärde F., Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke. 27:1996;1734-1738.
18. Fassbender K., Rossol S., Kammer T., Daffertshofer M., Wirth S., Dollman M., Hennerici M. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J. Neurol. Sci. 122:1994;135-139.
19. Foulkes M.A., Wolf P.A., Price T.R., Mohr J.P., Hier D.B. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 19:1998;547-554.
20. Grau A.J., Buggle F., Heindl S., Steichen-Wiehn C., Banerjee T., Maiwald M., Rohlfs M., Suhr H., Fiehn W., Becher H., Hacke W. Recent infection as a risk factor for cerebrovascular ischemia. Stroke. 26:1995;373-379.
21. Grau A.J., Buggle F., Steichen-Wiehn C., Heindl S., Banerjee T., Seitz R., Winter R., Forsting M., Werle E., Bode C., Nawroth P.P., Becher H., Hacke W. Clinical and biochemical analysis in infection-associated stroke. Stroke. 26:1995;1520-1526.
22. Grau A.J. Infection, inflammation and cerebrovascular ischemia. Neurology. 49:(Suppl. 4):1997;47-51.
23. Johanson A., Olsson T., Carlberg B., Karlsson K., Fagerlund M. Hypercortisolism after stroke - partly cytokine-mediated? J. Neurol. Sci. 147:1997;43-47.
24. Kim J.S. Cytokines and adhesion molecules in stroke and related diseases. J. Neurol. Sci. 137:1996;69-78.
25. Kim J.S., Yoon S.S., Kim Y.H., Ryu J.S. Serial measurement of interleukin-6, transforming grown factor-b, and S-100 protein in patients with acute stroke. Stroke. 27:1996;1553-1557.
26. Kochanek P.M., Hallenbeck J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 23:1992;1367-1379.
27. Liu T., McDonell P.C., Young P.R., White R.F., Siren A.L., Hallenbeck J.M., Barone F.C., Feuerstein G.Z. Interleukin-1b mRNA expression in ischemic rat cortex. Stroke. 24:1993;1746-1751.
28. Liu T., Clark R.K., McDonell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z. Tumor necrosis factor-α expression in ischemic neurons. Stroke. 25:1994;1481-1488.
29. Macko R.F., Ameriso S.F., Barndt R., Clough W., Weiner J.M., Fisher M. Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke. 27:1996;1999-2004.
30. Mathew N.T., Meyer J.S., Rivera V.M., Charney J.Z., Hartmann A. Double-blind evaluation of glycerol therapy in acute cerebral infarction. Lancet. 2:1972;1327-1329.
31. Myrvang A.K., Abrahamsen T.G. Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production. Thromb. Res. 80:1995;179-184.
32. Nawroth P.P., Handley D.A., Esmon C.T., Stern D. Interleukin-1 induces endothelial cell procoagulant activity while suppressing cell-surface anticoagulant activity. Proc. Natl. Acad. Sci. 83:1986;3460-3464.
33. Polis A.T., Foulkes M.A., Mohr J.P., Hier D.B., Price T.R., Wolf P.A. Representing computerized tomography scans using the GAMP procedure in SAS-Graph. Proc. SAS Users Group. Int. Conf. 14:1989;1162-1165.
34. Reith J., Jorgensen H.S., Pedersen P.M., Nakayama H., Raaschou H.O., Jeppesen L.L., Olsen T.S. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality and outcome. Lancet. 347:1996;422-425.
35. Rothlein R. Overview of leukocyte adhesion. Neurology. 49:(Suppl. 4):1997;3-4.
36. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system: actions and mechanisms of action. Trends. Neurosci. 18:1995;130-136.
37. Syrjanen J., Valtonen V.V., Iivanainen M., Huttunen J.K. Preceding infection as an important risk factor for ischemic brain infarction in young and middle age patients. Br. Med. J. 296:1988;1156-1160.
38. Syrjanen J., Teppo A.M., Valtonen V.V., Iivanainen M., Maury C.P.J. Acute phase response in cerebral infarction. J. Clin. Pathol. 42:1989;63-68.
39. Tarkowski E., Rosengren L., Blomstrand C., Wikkelsö C., Jensen C., Ekholm S., Tarkowski A. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 26:1995;1393-1398.
40. Toni D., De Michelle M., Fiorelli M. Influence of hyperglycemia on infarct size and clinical outcome of acute stroke patients with intracranial arterial occlusion. J. Neurol. Sci. 123:1994;129-133.
41. Van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J.A., van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 19:1988;604-607.
42. Van Deventer S.J.H., Büller H.R., ten Cate J.W., Aarden L.A., Hack C.E., Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood. 76:1990;2520-2526.
43. Vila N., Filella X., Deulofeu R., Chamorro A. Correlation between acute-phase reactants and cytokines in acute ischemic stroke. Cerebrovasc. Dis. 7:(Suppl. 4):1997;59.
44. Wang X.K., Yue T.L., Young P.R., Barone F.C., Feuerstein G.Z. Expression of interleukin-6,c-fos and zif268 mRNAs in rat ischemic cortex. J. Cereb. Blood Flow Metab. 15:1995;166-171.
45. Westergren A. Studies on the suspension stability of the blood in pulmonary tuberculosis. Acta Med. Scand. 54:1921;247-282.
46. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenic mediator of ischemic brain damage in rats. Stroke. 26:1995;676-681.